Skip to main content

Table 2 Univariate and multivariate analyses to identify predictors for poorer quality of life (SF-36) of caregivers in the total cohort, in patients with alcoholic liver cirrhosis, and in patients with non-alcoholic liver cirrhosis

From: Continued alcohol consumption and hepatic encephalopathy determine quality of life and psychosocial burden of caregivers in patients with liver cirrhosis

Variable

Univariate analysis

Multivariate analysis

r

p value

β

p value

Total cohort

    

 Continued alcohol consumption

0.259

0.079

0.292

0.003

 Psychosocial burden of caregivers (ZBI)

− 0.275

0.005

− 0.310

0.003

 Health-related Quality of life of patients (CLDQ)

0.182

0.062

0.139

0.167

Alcoholic liver cirrhosis

    

 Continued alcohol consumption

0.259

0.079

0.355

0.038

 Psychosocial burden of caregivers (ZBI)

− 0.275

0.005

− 0.264

0.135

 Health-related Quality of life of patient (CLDQ)

0.182

0.062

− 0.043

0.796

Non-alcoholic liver cirrhosis

    

 History of ascites

− 0.272

0.042

− 0.094

0.516

 History of SBP

− 0.359

0.007

− 0.216

0.091

 History of gastrointestinal bleeding

− 0.360

0.006

− 0.210

0.097

 Health-related Quality of life of patients (CLDQ)

0.344

0.009

0.071

0.610

 Psychosocial burden of caregivers (ZBI)

− 0.409

0.002

− 0.358

0.010

  1. Gender 1 for male, 2 for female; 1 for Alcohol consumption, 0 for no alcohol consumption; 1 for history of hepatic encephalopathy, 0 for no history of hepatic encephalopathy. Factors not predictive for SF-36 in the univariate analysis were gender, age, age of caregiver, sodium, creatine, bilirubin, albumin, INR, CRP, leucocytes, hemoglobin, platelets, MELD, Child–Pugh status, history of hepatorenal syndrome. With the remaining factors, a multivariate linear regression model with inclusion variable selection was built
  2. ZBI, Zarit burden interview; CLDQ, chronic liver disease questionnaire; SBP, spontaneous bacterial peritonitis; SF-36, Short Form Health 36; INR, international standardized ratio; CRP, C-reactive protein; MELD, model of end-stage liver disease